viewAdvanced Oncotherapy PLC

Advanced Oncotherapy receives first milestone payment

The payment was for a contract signed in March with Sinophi Healthcare.

The payment was for a contract signed in March with Sinophi Healthcare.

Advanced Oncotherapy (LON:AVO) has received a first milestone payment for its cancer treating LIGHT Proton Therapy System.

The payment was for a contract signed in March with Sinophi Healthcare for an oncology hospital project in Huai'an City, East China. 

Sinophi agreed to pay an initial US$40m for the LIGHT system through milestone payments, with the final price dependent on the treatment options it selects.

Advanced Onco added its new Geneva testing facility was also making progress and essential services such as electrical supplies, cooling systems and safety systems were now installed.

Sanjeev Pandya, Advanced Oncotherapy’s chief executive, said: “We remain on track to complete the technical development of the first LIGHT system so that it is ready for patient treatment in 2017 in Harley Street.

In addition, this first milestone payment from Sinophi for a LIGHT system order from China is a good reminder of the huge potential that China and Southeast Asia offers.

“We are very encouraged by the commercial interest that Sinophi is generating for us in the region."



Quick facts: Advanced Oncotherapy PLC

Price: 26.6 GBX

Market: LSE
Market Cap: £81.49 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Advanced Oncotherapy PLC named herein, including the promotion by the Company of Advanced Oncotherapy PLC in any Content on the Site, the...



Morning Report: Lloyds ends PPI headache; Sirius Minerals 'is quality' says...

Headlines from the Proactive UK newsroom. Anglo American (LON:AAL) has repeated that Sirius Minerals (LON:SXX) is a “quality” investment which is expected to “fit well” with the FTSE 100 group’s strategy. Anglo, which has made a bid for the firm, says the project in North Yorkshire is...

on 20/2/20

2 min read